Fasting hormone fibroblast growth factor 21 - new therapy for obesity and metabolic syndrome?

URN:NBN:SI:doc-PLSE97YE2009Fon Tacer, Klementinadocuments/doc/P/URN_NBN_SI_doc-PLSE97YE_001.htmdocuments/doc/P/URN_NBN_SI_doc-PLSE97YE_001.pdfdocuments/doc/P/URN_NBN_SI_doc-PLSE97YE_001.txt560articlestr. 251-2550014-822926146265URN:NBN:SI:doc-PLSE97YEslvSlovensko farmacevtsko društvoFarmacevtski vestnikInCdebelostdiabetes mellitushormonimetabolizemstradanjeFasting hormone fibroblast growth factor 21 - new therapy for obesity and metabolic syndrome?Hormon stradanja fibroblastni rastni dejavnik 21 - novo zdravilo za debelost in metabolni sindrom?